Our November issue focused on patient centricity with additional coverage around data management.
This November, Applied Clinical Trials focused on the topic of empowering patients. While technology has streamlined many operational aspects of clinical trials, it is also being leveraged to access more potential participants. The November issue of ACT explored some of those innovations and how they are giving more power to patients.
In addition to the current landscape of creating more patient-centric trials, ACT’s November issue focused on electronic methods for capturing clinical data including a use case from a hospital setting.
As we move into the month of December, the following slideshow provides a look back at the previously mentioned topics covered in November.
Image Credit: © Leafart - stock.adobe.com
Tecentriq Falls Short in Phase III Trial in Post-Surgery Triple-Negative Breast Cancer Patients
February 6th 2025In the ALEXANDRA/IMpassion030 trial, Tecentriq (atezolizumab) added to postoperative chemotherapy was not found to improve treatment outcomes for patients with high-risk early-stage triple-negative breast cancer.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.